Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced it was recognized by the life sciences industry at The Scientists' annual Life Science Industry Awards, winning in six categories.The Life Science Industry Awards have recognized top companies since 2002. For the third consecutive year Invitrogen was a finalist in twelve categories. Invitrogen won in six categories, the most of any company, including: Cell Biology Kits and Reagents, Cell Culture Media and Reagents, Most Responsive Customer Service, Most Knowledgeable Technical Support, Most Useful Web Site and Most Memorable Print Advertisement.
"To be recognized by thousands of life scientists as best-in-class in six categories is truly an outstanding accomplishment, a special accolade that our customers have bestowed upon us," said Greg Lucier, Chairman and Chief Executive Officer of Invitrogen. "As we celebrate our 20th year of accelerating scientific discovery, our commitment and passion for excellence in the life sciences continues to drive our innovative product offerings."
The Life Science Industry Awards are given to top life science suppliers. The winners of these prestigious awards are determined by the industry's own customers--scientists in biotechnology and pharmaceutical companies, in government and academia who use the products day in and day out. They are awarded by The Scientist magazine and sponsored by The Life Science Executive Exchange and The Science Advisory Board.
About Invitrogen
Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company is celebrating 20 years of accelerating scientific discovery. Invitrogen globally employs approximately 4,300 scientists and other professionals and had revenues of more than $1.26 billion in 2006. For more information, visit www.invitrogen.com
No comments:
Post a Comment